127 related articles for article (PubMed ID: 36764506)
1. Usefulness of lysophosphatidylcholine measurement in the cerebrospinal fluid for differential diagnosis of neuropathic pain: Possible introduction into clinical laboratory testing.
Kurano M; Sumitani M; Akiyama Y; Yamada M; Fujimura D; Yamaki S; Kano K; Aoki J; Hayakawa K; Takahashi T; Hirai T; Okawa A; Kume H; Ogata T; Tanaka S; Chikuda H; Yatomi Y
Clin Chim Acta; 2023 Feb; 541():117249. PubMed ID: 36764506
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Lysophosphatidylcholine Species for Distinguishing Narrowing of the Lumbar Spine.
Sumitani M; Kimura A; Mochizuki T; Akiyama T; Uranbileg B; Takahashi T; Hirai T; Hayakawa K; Chikuda H; Kurano M
World Neurosurg; 2024 Mar; 183():e571-e575. PubMed ID: 38181872
[TBL] [Abstract][Full Text] [Related]
3. Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study.
Edamura T; Sumitani M; Hayakawa K; Inoue R; Abe H; Tsuchida R; Chikuda H; Ogata T; Kurano M; Aoki J; Yatomi Y; Uchida K
Pain Ther; 2022 Dec; 11(4):1439-1449. PubMed ID: 36205847
[TBL] [Abstract][Full Text] [Related]
4. Spinal Cord Stimulation Alters Protein Levels in the Cerebrospinal Fluid of Neuropathic Pain Patients: A Proteomic Mass Spectrometric Analysis.
Lind AL; Emami Khoonsari P; Sjödin M; Katila L; Wetterhall M; Gordh T; Kultima K
Neuromodulation; 2016 Aug; 19(6):549-62. PubMed ID: 27513633
[TBL] [Abstract][Full Text] [Related]
5. Examination and characterisation of burst spinal cord stimulation on cerebrospinal fluid cellular and protein constituents in patient responders with chronic neuropathic pain - A Pilot Study.
Royds J; Conroy MJ; Dunne MR; Cassidy H; Matallanas D; Lysaght J; McCrory C
J Neuroimmunol; 2020 Jul; 344():577249. PubMed ID: 32361148
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.
Uranbileg B; Ito N; Kurano M; Saigusa D; Saito R; Uruno A; Kano K; Ikeda H; Yamada Y; Sumitani M; Sekiguchi M; Aoki J; Yatomi Y
Sci Rep; 2019 Nov; 9(1):16578. PubMed ID: 31719574
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis.
Hayakawa K; Kurano M; Ohya J; Oichi T; Kano K; Nishikawa M; Uranbileg B; Kuwajima K; Sumitani M; Tanaka S; Aoki J; Yatomi Y; Chikuda H
Sci Rep; 2019 Jun; 9(1):9144. PubMed ID: 31235770
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study.
Kuwajima K; Sumitani M; Kurano M; Kano K; Nishikawa M; Uranbileg B; Tsuchida R; Ogata T; Aoki J; Yatomi Y; Yamada Y
PLoS One; 2018; 13(11):e0207310. PubMed ID: 30408112
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Lysophospholipid Measurement in Cerebrospinal Fluid Samples using Liquid Chromatography-Tandem Mass Spectrometry.
Morita Y; Kurano M; Sakai E; Nishikawa M; Sawabe M; Aoki J; Yatomi Y
Lipids; 2019 Aug; 54(8):487-500. PubMed ID: 31243768
[TBL] [Abstract][Full Text] [Related]
11. Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine.
Zhao Z; Xu Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3739-42. PubMed ID: 19734112
[TBL] [Abstract][Full Text] [Related]
12. Very long chain acylcarnitines and lysophosphatidylcholines in screening of peroxisomal disease in children by tandem mass spectrometry.
Wang Y; Tian G; Ji W; Wang S; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):481-486. PubMed ID: 34704420
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus.
Wang HY; Tsai YJ; Chen SH; Lin CT; Lue JH
Pharmacol Biochem Behav; 2013 May; 106():47-56. PubMed ID: 23541495
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid levels of vascular endothelial growth factor correlate with reported pain and are reduced by spinal cord stimulation in patients with failed back surgery syndrome.
McCarthy KF; Connor TJ; McCrory C
Neuromodulation; 2013; 16(6):519-22; discussion 522. PubMed ID: 23136965
[TBL] [Abstract][Full Text] [Related]
16. Quantification of 10 elements in human cerebrospinal fluid from chronic pain patients with and without spinal cord stimulation.
Korvela M; Lind AL; Wetterhall M; Gordh T; Andersson M; Pettersson J
J Trace Elem Med Biol; 2016 Sep; 37():1-7. PubMed ID: 27473826
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid production from lysophosphatidylcholine by lysophospholipase D activity of autotaxin in plasma of women with normal and adverse pregnancies.
Tsutsumi T; Yasuda K; Neya M; Okada H; Tokumura A
Prostaglandins Other Lipid Mediat; 2022 Dec; 163():106670. PubMed ID: 35963509
[TBL] [Abstract][Full Text] [Related]
18. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
Zhao Z; Xiao Y; Elson P; Tan H; Plummer SJ; Berk M; Aung PP; Lavery IC; Achkar JP; Li L; Casey G; Xu Y
J Clin Oncol; 2007 Jul; 25(19):2696-701. PubMed ID: 17602074
[TBL] [Abstract][Full Text] [Related]
19. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
[TBL] [Abstract][Full Text] [Related]
20. Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes.
Honjo M; Igarashi N; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Weinreb RN; Aihara M
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):693-701. PubMed ID: 29392315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
